Hopkins AM - Search Results

1

A Transcriptional Link between HER2, JAM-A and FOXA1 in Breast Cancer.

Cruz RGB, Madden SF, Brennan K, Hopkins AM. Cruz RGB, et al. Among authors: hopkins am. Cells. 2022 Feb 19;11(4):735. doi: 10.3390/cells11040735. Cells. 2022. PMID: 35203384 Free PMC article.

2

JAM-A expression positively correlates with poor prognosis in breast cancer patients.

McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM. McSherry EA, et al. Among authors: hopkins am. Int J Cancer. 2009 Sep 15;125(6):1343-51. doi: 10.1002/ijc.24498. Int J Cancer. 2009. PMID: 19533747 Free article.

3

Tight junctions: a barrier to the initiation and progression of breast cancer?

Brennan K, Offiah G, McSherry EA, Hopkins AM. Brennan K, et al. Among authors: hopkins am. J Biomed Biotechnol. 2010;2010:460607. doi: 10.1155/2010/460607. Epub 2009 Nov 15. J Biomed Biotechnol. 2010. PMID: 19920867 Free PMC article. Review.

4

Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.

McSherry EA, Brennan K, Hudson L, Hill AD, Hopkins AM. McSherry EA, et al. Among authors: hopkins am. Breast Cancer Res. 2011 Mar 23;13(2):R31. doi: 10.1186/bcr2853. Breast Cancer Res. 2011. PMID: 21429211 Free PMC article.

5

Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.

Brennan K, McSherry EA, Hudson L, Kay EW, Hill AD, Young LS, Hopkins AM. Brennan K, et al. Among authors: hopkins am. Oncogene. 2013 May 30;32(22):2799-804. doi: 10.1038/onc.2012.276. Epub 2012 Jul 2. Oncogene. 2013. PMID: 22751120

6

Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis.

Leech AO, Cruz RG, Hill AD, Hopkins AM. Leech AO, et al. Among authors: hopkins am. Ann Transl Med. 2015 Aug;3(13):184. doi: 10.3978/j.issn.2305-5839.2015.08.01. Ann Transl Med. 2015. PMID: 26366401 Free PMC article. Review.

7

Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers.

Milewska M, Cremona M, Morgan C, O'Shea J, Carr A, Vellanki SH, Hopkins AM, Toomey S, Madden SF, Hennessy BT, Eustace AJ. Milewska M, et al. Among authors: hopkins am. Ther Adv Med Oncol. 2018 Jan 9;10:1758834017746040. doi: 10.1177/1758834017746040. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29383036 Free PMC article.

8

Adhesion in Physiological, Benign and Malignant Proliferative States of the Endometrium: Microenvironment and the Clinical Big Picture.

Rutherford EJ, Hill ADK, Hopkins AM. Rutherford EJ, et al. Among authors: hopkins am. Cells. 2018 May 16;7(5):43. doi: 10.3390/cells7050043. Cells. 2018. PMID: 29772648 Free PMC article. Review.

9

Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.

Vellanki SH, Cruz RGB, Jahns H, Hudson L, Sette G, Eramo A, Hopkins AM. Vellanki SH, et al. Among authors: hopkins am. Cancer Lett. 2019 Jan;440-441:23-34. doi: 10.1016/j.canlet.2018.09.032. Epub 2018 Oct 9. Cancer Lett. 2019. PMID: 30312728 Free article.

10

Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.

Leech AO, Vellanki SH, Rutherford EJ, Keogh A, Jahns H, Hudson L, O'Donovan N, Sabri S, Abdulkarim B, Sheehan KM, Kay EW, Young LS, Hill ADK, Smith YE, Hopkins AM. Leech AO, et al. Among authors: hopkins am. Breast Cancer Res. 2018 Nov 20;20(1):140. doi: 10.1186/s13058-018-1064-1. Breast Cancer Res. 2018. PMID: 30458861 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page